Dialysis News and Research

Latest Dialysis News and Research

Group education is an effective way to help alleviate organ shortage and increase living donations

Get-togethers with a kidney disease patient's family and friends can improve their willingness to consider donation, according to a paper being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, CA.

30 Oct 2009

Reading levels of kidney transplant consent forms can make it difficult for patients to make informed decisions

Kidney transplant consent forms are often written at a level that makes it difficult for many kidney patients to fully understand them, according to a paper being presented at the American Society of Nephrology's annual meeting in San Diego, CA. The study findings indicate that consent forms are written on average at a 12th-grade reading level, but to ensure all patients fully comprehend treatment options should be prepared at a 5th - 8th grade reading level.

30 Oct 2009

Anabolic steroids may cause severe kidney dysfunction

Athletes who use anabolic steroids may gain muscle mass and strength, but they can also destroy their kidney function, according to a paper being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, CA.

30 Oct 2009

Dynavax Technologies announces first clinical data for HEPLISAV investigational hepatitis B vaccine

Dynavax Technologies Corporation today announced the first clinical data for HEPLISAVTM investigational hepatitis B vaccine in chronic kidney disease patients.

30 Oct 2009

Vitamin D deficiency may account for increased risk of end-stage renal disease in African Americans

Low levels of vitamin D may account for nearly 60 percent of the elevated risk of end-stage renal disease (ESRD) in African Americans, according to a report in the December Journal of the American Society of Nephrology (JASN).

30 Oct 2009

Unaudited consolidated financial results for the third-quarter reported by AMAG Pharmaceuticals

AMAG Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease, today reported unaudited consolidated financial results for the third quarter and nine months ended September 30, 2009.

29 Oct 2009

Debilitating muscle weakness can linger long after hospital discharge

After decades of focusing on the management of respiratory failure, circulatory shock and severe infections that lead to extended stays in hospital intensive care units, critical care researchers are increasingly turning attention to what they believe is a treatable complication developed by many who spend days or weeks confined to an ICU bed: debilitating muscle weakness that can linger long after hospital discharge.

28 Oct 2009

Noncardiovascular mortality are rates higher in patients receiving dialysis

Compared to the general population, patients starting dialysis have an increased risk of death that is not attributable to a higher rate of death from cardiovascular causes, as previously thought, according to a study in the October 28 issue of JAMA.

28 Oct 2009

Shire receives European approval for FOSRENOL

Shire plc, the global specialty biopharmaceutical company, today announced it has received approval through the European Mutual Recognition Procedure for an extension to the current indication for FOSRENOL(R) (lanthanum carbonate), paving the way to make the non-calcium, non-resin phosphate binder available throughout the EU to control hyperphosphataemia in chronic kidney disease (CKD) patients who are not on dialysis with a serum phosphorus level greather than or equal to 1.78mmol/L (5.5mg/dL).

28 Oct 2009

Interim results from FREEDOM study announced by NxStage Medical

NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, today announced the latest interim results from its ongoing FREEDOM study. The FREEDOM data will be presented in posters at the American Society of Nephrology (ASN) Renal Week 2009, from October 27th to November 1st in San Diego.

27 Oct 2009

Bioconnect Systems to present clinical study of Optiflow device at ASN Meeting in San Diego

Bioconnect Systems, Inc. announced today that data from the Company's first clinical study will be presented this week at the ASN Meeting in San Diego. Bioconnect’s implant platform, the Optiflow™, enhances a surgeon’s ability to create precise vascular connections.

27 Oct 2009

PolyMedix completes second successful clinical study of PMX-60056

PolyMedix, Inc. (http://polymedix.com), an emerging biotechnology company developing new therapeutic drug products to treat infectious diseases and acute cardiovascular disorders, has completed a second successful clinical study of its anticoagulant reversing agent, PMX-60056.

27 Oct 2009

Bayshore Home Health acquires Nightingale Nursing Group

Bayshore Home Health announced today the purchase of Saskatoon-based home health care company Nightingale Nursing Group Inc. The acquisition expands Bayshore's presence in the province, complements its existing office in Regina, and provides an opportunity to service additional remote northern communities.

27 Oct 2009

Additional CFTR inhibitor technology licensed to Napo Pharmaceuticals

Napo Pharmaceuticals, Inc. has in-licensed from the University of California Regents additional small-molecule cystic fibrosis transmembrane conductance regulator (CFTR) inhibitor technology including gastrointestinal (GI) and polycystic kidney disease (PKD) indications.

26 Oct 2009

DaVita to demonstrate clinical outcomes, patient care and nutrition through 43 abstracts

DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), in conjunction with DaVita Clinical Research®, today announced that company representatives will deliver 43 abstracts—40 posters and three oral presentations—at this year’s American Society of Nephrology’s (ASN) Renal Week to be held in San Diego, Calif., from Oct. 27 – Nov. 1, 2009.

24 Oct 2009

Study shows appropriate use of CRRT improves AKI patient outcomes

A study appearing today in the New England Journal of Medicine adds to the growing body of evidence supporting continuous renal replacement therapy (CRRT) as the therapy of choice for treatment of acute kidney injury (AKI) patients in the intensive care unit (ICU).

23 Oct 2009

Affymax to make multiple presentations on preclinical and clinical data of Hematide

Affymax, Inc. today announced multiple presentations at the American Society of Nephrology (ASN) Renal Week 2009 taking place October 27 through November 1 in San Diego.

23 Oct 2009

MUSC launches Social Media Newsroom for real-time information on medical news and research

As the editorial landscape continues to evolve with the emergence of social media, many people struggle to find trusted resources that offer accurate, real time information related to healthcare news and research.

21 Oct 2009

APP Pharmaceuticals to launch Chlorothiazide Sodium for Injection

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Chlorothiazide Sodium for Injection, USP. APP expects to launch Chlorothiazide Sodium for Injection, USP in the fourth quarter of 2009.

21 Oct 2009

Massachusetts seeks to cut increase in small business health care costs

Today's state news covers access to care issues in Florida and California, a new proposal to review premiums charged to small business, and the potential flaws of Ohio's nursing home payment plan.

21 Oct 2009

Dialysis News and Research

Latest Dialysis News and Research

Group education is an effective way to help alleviate organ shortage and increase living donations

Reading levels of kidney transplant consent forms can make it difficult for patients to make informed decisions

Anabolic steroids may cause severe kidney dysfunction

Dynavax Technologies announces first clinical data for HEPLISAV investigational hepatitis B vaccine

Vitamin D deficiency may account for increased risk of end-stage renal disease in African Americans

Unaudited consolidated financial results for the third-quarter reported by AMAG Pharmaceuticals

Debilitating muscle weakness can linger long after hospital discharge

Noncardiovascular mortality are rates higher in patients receiving dialysis

Shire receives European approval for FOSRENOL

Interim results from FREEDOM study announced by NxStage Medical

Bioconnect Systems to present clinical study of Optiflow device at ASN Meeting in San Diego

PolyMedix completes second successful clinical study of PMX-60056

Bayshore Home Health acquires Nightingale Nursing Group

Additional CFTR inhibitor technology licensed to Napo Pharmaceuticals

DaVita to demonstrate clinical outcomes, patient care and nutrition through 43 abstracts

Study shows appropriate use of CRRT improves AKI patient outcomes

Affymax to make multiple presentations on preclinical and clinical data of Hematide

MUSC launches Social Media Newsroom for real-time information on medical news and research

APP Pharmaceuticals to launch Chlorothiazide Sodium for Injection

Massachusetts seeks to cut increase in small business health care costs

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Dialysis News and Research

Latest Dialysis News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in